Genomic variation in epidemic carbapenem-resistant K.pneumoniae
流行性耐碳青霉烯类肺炎克雷伯菌的基因组变异
基本信息
- 批准号:9035583
- 负责人:
- 金额:$ 23.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-01-01 至 2017-12-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAntibiotic ResistanceAntibioticsAntigensAutomobile DrivingBacteremiaBacteriaBiologicalBiological AssayCenters for Disease Control and Prevention (U.S.)CharacteristicsChromosome StructuresChromosomesClinicalDataDevelopmentDiagnosticDiagnostic testsDiseaseEffectivenessEpidemicEpidemiologyFutureGenerationsGenesGeneticGenetic RecombinationGenetic VariationGenomeGenomicsGoalsHospitalsHumanHybridsImmune responseImmunityImmunocompromised HostIn VitroInfectionInheritedKlebsiella pneumonia bacteriumLeadMeasuresMobile Genetic ElementsModelingMolecular EvolutionMolecular GeneticsMorbidity - disease rateMulti-Drug ResistanceNosocomial InfectionsOperonOther GeneticsPlasmidsPolysaccharidesPublic DomainsRecombinantsRecording of previous eventsResistanceRoleSerumSourceStreptococcus pneumoniaeSurface AntigensTestingTherapeuticUnited StatesVaccinesVariantVirulenceVirulence FactorsVirulentantimicrobialcapsulecarbapenem resistancecarbapenem-resistant Enterobacteriaceaecarbapenemasecombatcomparative genomicsdriving forcegene synthesisgenetic variantgenome sequencinggenomic variationin vivoin vivo Modelmortalitymouse modelneutrophilnovelnovel therapeuticspathogenpathogenic bacteriapressurepublic health relevanceresistant strainsuccesstransmission processwhole genome
项目摘要
DESCRIPTION (provided by applicant)
Carbapenem-resistant Enterobacteriaceae (CRE), especially Klebsiella pneumoniae carbapenemase (KPC)- producing K. pneumoniae (KPC-Kp), have emerged as a significant hospital-acquired pathogen causing considerable morbidity and mortality in the United States and worldwide. Strikingly, a large majority of KPC-Kp isolates belong to a single sequence type, ST258. However, the molecular evolution of this epidemic clone is still very poorly understood and the genetic factors contributing to its epidemiological success remain unknown. Recent comparative genomic studies indicate that Kp ST258 strains are undergoing significant diversification in both plasmid and chromosome structures, especially at the K-antigen encoded capsular polysaccharides synthesis (cps) gene operons. Similar to what has been described in other pathogenic bacteria (e.g. Streptococcus pneumoniae), the recombination of cps-harboring region appears to be a major driving force in the genetic diversification in ST258. To date, we have found six different cps operons (cps-1 to -6) in Kp ST258 strains and identified several ST258 associated blaKPC-harboring plasmids. Notably, our preliminary data showed the variations in ST258 clades (different cps groups) are not limited to the cps regions, but also involve multiple loci that harbor genes contributing to colonization, resistance and virulence. One significant concern is that this epidemic clone may acquire enhanced virulence via chromosomal recombination and/or plasmid transfer, evolving as a highly virulent, multidrug resistant (HV-MDR) strain and further complicating current efforts to battle this crisis. Alarmingly, our preliminary results showed that certain "new" Kp ST258 clades (i.e. harboring novel cps operons) had higher virulence in comparison to strains from other circulating clades. Thus, we hypothesize that variable chromosomal regions and/or acquired plasmids alter host-pathogen interactions that may lead to the emergence of strains of enhanced virulence. Our objective is to identify these genomic factors and plasmid contents, and characterize their biological role associated with ST258 virulence, and examine plasmid transmissibility. In this application, we will investigate the extent to which genetic recombination has influenced genetic variation in Kp ST258. Through whole genome sequencing (WGS) of representative Kp isolates from different cps groups (cps-1 to cps-6) as well as their putative donor strains (unique STs that are likely the source of the cps replacement in ST258), we will systematically evaluate both large and small scale genomic variations in this epidemic clone and elucidate their molecular evolution history (Aim 1). Next, by using in vitro and in vivo models, we will investigate whether recombination that results in replacement of capsule-encoding machinery as well as other biologically important loci results in the emergence of HV-MDR clades (Aim 2a). In addition, we will test the hypothesis that ST258 genetic background has higher transfer efficiency and stability for KPC plasmids, which may partly explain the success of this KPC epidemic clone (Aim 2b). The results generated in this study will yield a wealth of information regarding the content and characteristics of Kp genomic variations and will likely identify novel virulence factors. The identification of genomic variations that impact the disease-causing potential of Kp strains will provide potential diagnostic and therapeutic solutions.
描述(由申请人提供)
耐碳青霉烯类肠杆菌科 (CRE),尤其是产肺炎克雷伯菌碳青霉烯酶 (KPC) 的肺炎克雷伯菌 (KPC-Kp),已成为一种重要的医院获得性病原体,在美国和全世界造成相当大的发病率和死亡率。引人注目的是,绝大多数 KPC-Kp 分离株属于单一序列类型 ST258。然而,人们对这种流行性克隆的分子进化仍然知之甚少,导致其流行病学成功的遗传因素仍然未知。最近的比较基因组研究表明,Kp ST258 菌株在质粒和染色体结构方面正在经历显着的多样化,特别是在 K 抗原编码的荚膜多糖合成 (cps) 基因操纵子上。与其他病原菌(例如肺炎链球菌)中所描述的类似,cps 携带区域的重组似乎是 ST258 遗传多样化的主要驱动力。迄今为止,我们在 Kp ST258 菌株中发现了 6 个不同的 cps 操纵子(cps-1 至 -6),并鉴定了几个 ST258 相关的 blaKPC 携带质粒。值得注意的是,我们的初步数据显示 ST258 进化枝(不同 cps 组)的变异不仅限于 cps 区域,还涉及多个位点,这些位点含有有助于定植、抗性和毒力的基因。一个重要的担忧是,这种流行性克隆可能通过染色体重组和/或质粒转移获得增强的毒力,演变成一种高毒力、多重耐药(HV-MDR)菌株,并使当前应对这一危机的努力进一步复杂化。令人震惊的是,我们的初步结果表明,某些“新”Kp ST258 分支(即携带新的 cps 操纵子)与其他流行分支的菌株相比具有更高的毒力。因此,我们假设可变染色体区域和/或获得性质粒改变宿主-病原体相互作用,可能导致毒力增强菌株的出现。我们的目标是鉴定这些基因组因子和质粒内容,并表征它们与 ST258 毒力相关的生物学作用,并检查质粒的传播性。在此应用中,我们将研究基因重组对 Kp ST258 遗传变异的影响程度。通过对来自不同 cps 组(cps-1 至 cps-6)的代表性 Kp 分离株及其假定的供体菌株(可能是 ST258 中 cps 替代来源的独特 ST)进行全基因组测序(WGS),我们将系统地评估该流行克隆中的大规模和小规模基因组变异,并阐明其分子进化历史(目标 1)。接下来,通过使用体外和体内模型,我们将研究导致胶囊编码机制以及其他生物学重要位点替换的重组是否导致 HV-MDR 进化枝的出现(目标 2a)。此外,我们将测试 ST258 遗传背景对 KPC 质粒具有更高的转移效率和稳定性的假设,这可能部分解释了该 KPC 流行克隆的成功(目标 2b)。本研究产生的结果将产生有关 Kp 基因组变异的内容和特征的大量信息,并可能识别新的毒力因子。影响 Kp 菌株致病潜力的基因组变异的鉴定将提供潜在的诊断和治疗解决方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liang Chen其他文献
Liang Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Liang Chen', 18)}}的其他基金
Investigate the immune modulation function of SARS-CoV-2 accessory protein ORF8
研究SARS-CoV-2辅助蛋白ORF8的免疫调节功能
- 批准号:
469610 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
COVID-19 Variant Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
COVID-19 变异补充剂 - 了解 COVID-19 病毒的高致病性和人畜共患传播:逃避宿主先天免疫反应
- 批准号:
442863 - 财政年份:2021
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
了解 COVID-19 病毒的高致病性和人畜共患传播:逃避宿主先天免疫反应
- 批准号:
422747 - 财政年份:2020
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
Sex as a Biological Variable Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
性别作为生物变量补充 - 了解 COVID-19 病毒的高致病性和人畜共患传播:逃避宿主先天免疫反应
- 批准号:
424691 - 财政年份:2020
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
Understanding the NMD regulatory path from genetic variation to phenotypes
了解 NMD 从遗传变异到表型的调控路径
- 批准号:
10377405 - 财政年份:2020
- 资助金额:
$ 23.85万 - 项目类别:
Understanding the NMD regulatory path from genetic variation to phenotypes
了解 NMD 从遗传变异到表型的调控路径
- 批准号:
10714885 - 财政年份:2020
- 资助金额:
$ 23.85万 - 项目类别:
Understanding the NMD regulatory path from genetic variation to phenotypes
了解 NMD 从遗传变异到表型的调控路径
- 批准号:
10594582 - 财政年份:2020
- 资助金额:
$ 23.85万 - 项目类别:
Novel approaches to identify regulators of Bak1 splicing
识别 Bak1 剪接调节因子的新方法
- 批准号:
10040977 - 财政年份:2020
- 资助金额:
$ 23.85万 - 项目类别:
Study IFITM restriction of HIV-1 entry: cross-talk with adaptive immunity
研究 IFITM 对 HIV-1 进入的限制:与适应性免疫的交叉对话
- 批准号:
401410 - 财政年份:2019
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
Overcome HIV-1 Resistance to CRISPR/Cas9 Attack
克服 HIV-1 对 CRISPR/Cas9 攻击的抵抗力
- 批准号:
350800 - 财政年份:2016
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
相似海外基金
The effects of antibiotics to the transfer frequency of the antibiotic resistance genes and the evolution of high-level resistance.
抗生素对抗生素抗性基因转移频率和高水平抗性进化的影响。
- 批准号:
22K05790 - 财政年份:2022
- 资助金额:
$ 23.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NEC05839 Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
NEC05839 先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
- 批准号:
NE/N019687/2 - 财政年份:2019
- 资助金额:
$ 23.85万 - 项目类别:
Research Grant
Combating Antibiotic Resistance to Aminoglycoside Antibiotics through Chemical Synthesis
通过化学合成对抗氨基糖苷类抗生素的耐药性
- 批准号:
392481159 - 财政年份:2017
- 资助金额:
$ 23.85万 - 项目类别:
Research Fellowships
NEC05839 Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
NEC05839 先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
- 批准号:
NE/N019687/1 - 财政年份:2016
- 资助金额:
$ 23.85万 - 项目类别:
Research Grant
Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
- 批准号:
NE/N019857/1 - 财政年份:2016
- 资助金额:
$ 23.85万 - 项目类别:
Research Grant
The SuDDICU study- A study of the impact of preventative antibiotics (SDD) on patient outcome and antibiotic resistance in the critically ill in intensive care
SuDDICU 研究 - 一项关于预防性抗生素 (SDD) 对重症监护病危患者的患者预后和抗生素耐药性影响的研究
- 批准号:
366555 - 财政年份:2016
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
Chicken or the Egg: Is AMR in the Environment Driven by Dissemination of Antibiotics or Antibiotic Resistance Genes?
先有鸡还是先有蛋:环境中的抗菌素耐药性是由抗生素或抗生素抗性基因的传播驱动的吗?
- 批准号:
NE/N019717/1 - 财政年份:2016
- 资助金额:
$ 23.85万 - 项目类别:
Research Grant
The SuDDICU study- A study of the impact of preventative antibiotics (SDD) on patient outcome and antibiotic resistance in the critically ill in intensive care
SuDDICU 研究 - 一项关于预防性抗生素 (SDD) 对重症监护病危患者的患者预后和抗生素耐药性影响的研究
- 批准号:
361307 - 财政年份:2016
- 资助金额:
$ 23.85万 - 项目类别:
Operating Grants
Contamination status of antibiotics and antibiotic resistance genes (ARGs) in tropical Asian aquatic environments with artificial and natural disturbance
人工和自然干扰下亚洲热带水生环境中抗生素和抗生素抗性基因(ARG)的污染状况
- 批准号:
25257402 - 财政年份:2013
- 资助金额:
$ 23.85万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
RAPID: COLLABORATIVE RESEARCH: Fate and Transport of Antibiotics and Antibiotic Resistance Genes During Historic Colorado Flood
快速:合作研究:历史性科罗拉多洪水期间抗生素和抗生素抗性基因的命运和运输
- 批准号:
1402635 - 财政年份:2013
- 资助金额:
$ 23.85万 - 项目类别:
Standard Grant